Prosecution Insights
Last updated: October 25, 2026

Lathrop Gpm LLP: all pending office actions

← Back to Lathrop Gpm LLP

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19568680 YEAST CELL WALL PARTICLE ENCAPSULATION OF BIODEGRADABLE PRO-PAYLOADS UNIVERSITY OF MASSACHUSETTS VANHORN, ABIGAIL LOUISE 1636 §103§112DP Non-Final OA — Pending Mar 16, 2026
19395349 USE OF PASTEURIZED AKKERMANSIA FOR TREATING METABOLIC DISORDERS Compagnie Gervais Danone NGUYEN, NGHI V 1653 §102Other Final Rejection — Pending Nov 20, 2025
19378987 PORTABLE CONTAINER WITH SIMULTANEOUS COLLAPSIBLE SUPPORT FEET Packfire, Inc. CASTELLANO, STEPHEN J 3733 §102§103§112 Final Rejection — Pending Nov 04, 2025
19354420 METHODS AND SYSTEMS TO INDUCE REFLECTION BASED ON EMOTIONAL VALENCE Sequelae, Inc. O'SHEA, BRENDAN S 3626 §101§102§103 Non-Final OA — Pending Oct 09, 2025
19325002 SYSTEM AND DEVICE FOR MAXILLOMANDIBULAR FIXATION Invisian Medical, LLC RUIZ MARTIN, LUIS MIGUEL 3772 §103 Final Rejection — Pending Sep 10, 2025
19321862 METHODS AND SYSTEMS FOR IMPROVING AN EFFECTIVENESS OF REFLECTION BY AN INDIVIDUAL MEMBER Sequelae, Inc. COBANOGLU, DILEK B 3687 §101§102§112 Non-Final OA — Pending Sep 08, 2025
19322416 SYSTEMS AND METHODS FOR SCORING LANGUAGE MODEL OUTPUTS USING A SCORING MODEL Cable Television Laboratories, Inc. CAIADO, ANTONIO J 2164 §101§102§103 Non-Final OA — Pending Sep 08, 2025
19301806 TRAJECTORY VALUE LEARNING FOR AUTONOMOUS SYSTEMS Waabi Innovation Inc. NGUYEN, TAN QUANG 3661 DP Non-Final OA — Pending Aug 15, 2025
19287736 ADAPTIVE AUTO-DRILLING FOR DRILLING APPLICATIONS Flanders Electric Motor Service, LLC WLODARSKI, NICHOLAS NMN 3672 §101 Final Rejection — Pending Jul 31, 2025
19271284 PHARMACEUTICAL FORMULATIONS FOR SUBCUTANEOUS ADMINISTRATION OF FUROSEMIDE Scpharmaceuticals Inc. HUANG, GIGI GEORGIANA 1613 §103DP Non-Final OA 7d Pending Jul 16, 2025
19269487 ANTIBODY-DRUG CONJUGATES USING TWO DIFFERENT TYPES OF TOPOISOMERASE I INHIBITORS Araris Biotech AG VISHNYAKOVA, ELENA VLADIMIROVNA 1691 §103§112DP Non-Final OA — Pending Jul 15, 2025
19137361 MEASUREMENT DEVICE AND DRILL GUIDE Arthrex, Inc. SIPP, AMY R. 3775 §102§103§112 Final Rejection — Pending Jun 10, 2025
19224021 USE OF AKKERMANSIA FOR TREATING METABOLIC DISORDERS Wageningen Universiteit GOUGH, TIFFANY MAUREEN 1651 §101DP Final Rejection — Pending May 30, 2025
19222001 SYSTEMS AND METHODS FOR QUANTIFYING NETWORK QUALITY USING A SCORING MODEL Cable Television Laboratories, Inc. HUSSAIN, TAUQIR 2449 §101§103 Non-Final OA — Pending May 29, 2025
19210707 SYSTEMS AND METHODS FOR AUTOMATICALLY GENERATING A RECORD IN A DIGITAL COMMUNICATION NETWORK Sequelae, Inc. LAGOY, KYRA RAND 3685 §101§103 Final Rejection — Pending May 16, 2025
19120654 ANTIFIBROTIC AGENT, PHARMACEUTICAL COMPOSITION FOR TREATING FIBROSIS, AND METHOD FOR INACTIVATING MYOFIBROBLASTS Somar Corporation LI, WENHAN 1614 §103§112DP Non-Final OA — Pending Apr 11, 2025
19174814 ARTIFICIAL INTELLIGENCE POWERED CHIEF OF STAFF BOT TransforML Platforms Inc. FILIPCZYK, MARCIN R 2153 §103 Final Rejection 23d overdue Pending Apr 09, 2025
19114282 NEURAL HASH GRID BASED MULTI-SENSOR SIMULATION Waabi Innovation Inc. LI, JAI WEI TOMMY 2613 §103 Non-Final OA — Pending Mar 21, 2025
19083908 SYSTEMS AND METHODS FOR SUPPORTING HEALTH-BASED COMMUNICATIONS Sequelae, Inc. SIOZOPOULOS, CONSTANTINE B 3686 §101§102 Non-Final OA — Pending Mar 19, 2025
19073684 SYSTEMS AND METHODS FOR INCENTIVIZING HEALTH-BASED INTERVENTIONS BASED ON INFLUENCE IN A DIGITAL COMMUNICATION NETWORK Sequelae, Inc. RASNIC, HUNTER J 3684 §101§103 Final Rejection — Pending Mar 07, 2025
19072084 METHODS AND SYSTEMS FOR DETERMINING AN INTERVENTION BASED TREATMENT FOR CHRONIC MEDICAL CONDITIONS Sequelae, Inc. GARTLAND, SCOTT D 3685 §101 Final Rejection — Pending Mar 06, 2025
19065033 METHODS AND SYSTEMS FOR DETERMINING STRESS RESILIENCY Sequelae, Inc. SAINT-VIL, EDDY 3715 §101§103 Non-Final OA — Pending Feb 27, 2025
18980424 BICYCLOOCTANE KRAS INHIBITORS Incyte Corporation RAHMANI, NILOOFAR 1691 §102§112 Non-Final OA — Pending Dec 13, 2024
18949302 ROAD MAPPING FRAMEWORK Waabi Innovation Inc. LIN, JESSICA YIFANG 2668 §102§103 Non-Final OA — Pending Nov 15, 2024
18948416 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHOLOGICAL DISORDERS Alkermes Pharma Ireland Limited WARD, PAUL V 1622 §112DP Non-Final OA — Pending Nov 14, 2024
18936436 SYSTEM AND METHOD FOR PLANK PROCESSING Shaw Industries Group, Inc. MUDD, HENRY HOOPER 3642 §102 Non-Final OA — Pending Nov 04, 2024
18925317 SYSTEMS AND METHODS FOR RECONFIGURABLE COHERENT PON Cable Television Laboratories, Inc. PHAN, HANH 2634 §103 Non-Final OA — Pending Oct 24, 2024
18900771 SYNTHESIS AND COMPOSITION OF PHOTODYNAMIC THERAPEUTIC AGENTS FOR THE TARGETED TREATMENT OF CANCER On Target Laboratories, Inc. DICKINSON, PAUL W 1618 §101§112 Non-Final OA — Pending Sep 29, 2024
18896259 N-OXIDE INHIBITORS OF NLRP3 INFLAMMASOME BIOAGE LABS, INC. RAHMANI, NILOOFAR 1691 §112DP Non-Final OA — Pending Sep 25, 2024
18849834 3,4,6,7-TETRAHYDRO-2,7-NAPHTHYRIDINE-2(1H)-CARBOXAMIDE DERIVATIVES AS GPR65 INHIBITORS FOR THE TREATMENT OF CANCER AND AUTOIMMUNE DISEASES Pathios Therapeutics Limited STOCKTON, LAURA LYNNE 1626 §102§112 Non-Final OA — Pending Sep 23, 2024
18886490 BALLOON INFLATION SYSTEM AND METHODS Anagram International, LLC KASENGE, CHARLES R 2116 §102 Non-Final OA — Pending Sep 16, 2024
18841615 SYSTEMS AND METHODS FOR CAPILLARY ISOELECTRIC FOCUSING-MASS SPECTROMETRY (CIEF-MS) ISOELECTRIC POINT (pI) CALIBRATION DH TECHNOLOGIES DEVELOPMENT PTE. LTD. WANG, JING 2881 §101§103§112 Non-Final OA — Pending Aug 26, 2024
18839971 METHOD FOR CHECK MEASUREMENT OF A LOG PROCESSED WITH TREE-HANDLING DEVICE, CORRESPONDING MEASUREMENT SYSTEM, FOREST MACHINE AND HARDWARE Ponsse Oyj QUINN, DANIEL MICHAEL 2855 §101§102§103§112 Non-Final OA — Pending Aug 20, 2024
18835285 AUTONOMOUS SYSTEM TRAINING AND TESTING Waabi Innovation Inc. TSWEI, YU-JANG 2614 §103 Final Rejection 9d Pending Aug 01, 2024
18832725 LIQUID FORMULATION COMPRISING A FUSION PROTEIN INCLUDING a-GALACTOSIDASE A Hanmi Pharm. Co., Ltd. CRAIGO, WILLIAM A 1615 §103Other Final Rejection — Pending Jul 24, 2024
18780957 HIDDEN EDGE FOR FLOORING FINISHING Columbia Insurance Company MAESTRI, PATRICK J 3635 §102§103 Non-Final OA 28d Pending Jul 23, 2024
18729403 HETEROCYCLIC COMPOUNDS AS UBIQUITIN SPECIFIC PROTEASE 7 INHIBITORS Almac Discovery Limited HEITMEIER, KENDALL NICOLE 1621 §103§112DP Non-Final OA — Pending Jul 16, 2024
18759774 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR Arvinas Operations, Inc. RAHMANI, NILOOFAR §103 Non-Final OA — Pending Jun 28, 2024
18724755 REFRIGERATED PROCESSED FOODS OF EXTENDED DURABILITY AND METHOD FOR THE CONSERVATION THEREOF Coroos Beheer BV LEFF, STEVEN N 1792 §103§112 Non-Final OA — Pending Jun 27, 2024
18722680 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING SGLT-2 INHIBITOR AND GOSSYPOL Haim Bio., Ltd. GALSTER, SAMUEL LEONARD 1693 §103§112 Non-Final OA — Pending Jun 21, 2024
18717119 DECORATIVE ARTICLE DELIVERY DEVICE Shaw Industries Group, Inc. STABLEY, MICHAEL R 3611 §102§103§112 Non-Final OA — Pending Jun 06, 2024
18715638 CAPILLARY ELECTROPHORESIS METHODS FOR CHARACTERIZING GENOME INTEGRITY DH TECHNOLOGIES DEVELOPMENT PTE. LTD. CHEN, STACY BROWN 1672 §103 Non-Final OA — Pending May 31, 2024
18678931 TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS Incyte Corporation AULAKH, CHARANJIT 1621 §112 Final Rejection — Pending May 30, 2024
18675743 PYRAZOLOQUINOLINE KRAS INHIBITORS Incyte Corporation RAHMANI, NILOOFAR 1691 §102 Non-Final OA — Pending May 28, 2024
18705038 USE OF A MODIFIED B-CAROTENE KETOLASE (BKT) OR A CORRESPONDING NUCLEIC ACID FOR IMPROVING RESISTANCE TO OXIDATIVE STRESS AND/OR PHOTOINHIBITION OF HOST ORGANISMS, IMPROVING BIOMASS PRODUCTIVITY OF HOST ORGANISMS AND/OR PREVAILING OVER OTHER COMPETING ORGANISMS UPON CULTIVATION IN HIGH LIGHT CONDITIONS Universita' Degli Studi Di Verona POLIAKOVA-GEORGAN, EKATERINA 1651 §103§112 Non-Final OA — Pending Apr 26, 2024
18639584 METHODS FOR PRODUCING ANTIBODY-LINKER CONJUGATES Araris Biotech AG GUSTILO, ESTELLA M 1646 §102Other Non-Final OA — Pending Apr 18, 2024
18638034 CYCLIC UREA KRAS INHIBITORS Incyte Corporation KIFLE, BRUCK 1624 §112 Final Rejection — Pending Apr 17, 2024
18701106 PROCESSES FOR PREPARING RADIOLABELLED CONJUGATES University Of Sydney WESTERBERG, NISSA M 1618 §103§112Other Non-Final OA — Pending Apr 12, 2024
18699825 TRICYCLIC GPR65 MODULATORS Pathios Therapeutics Limited KENYON, JOHN S 1625 §112DP Non-Final OA — Pending Apr 09, 2024
18698440 SOFTWARE FOR MICROFLUIDIC SYSTEMS INTERFACING WITH MASS SPECTROMETRY Intabio, LLC NIMOX, RAYMOND LONDALE 2857 §101§103 Non-Final OA — Pending Apr 04, 2024
18698595 Wound Management Systems Arthrex, Inc. STEPHENS, JACQUELINE F 3781 §103 Final Rejection 12d Pending Apr 04, 2024
18696689 MULTISPECIFIC BINDING AGENTS AGAINST PD-L1 AND CD137 IN COMBINATION THERAPY BIONTECH SE GUSTILO, ESTELLA M 1646 §102§103§112Other Non-Final OA — Pending Mar 28, 2024
18694663 MEDICAMENT COMPRISING A P2X4 RECEPTOR ANTAGONIST FOR PREVENTING OR TREATING NOCICEPTIVE PAIN AND/OR VISCERAL PAIN Nippon Chemiphar Co., Ltd. RAHMANI, NILOOFAR 1691 §102§112 Non-Final OA — Pending Mar 22, 2024
18694631 REGENERATIVE AGENT FOR BONE TISSUE AND LUNG TISSUE, AND PHARMACEUTICAL COMPOSITION FOR REGENERATING BONE TISSUE AND LUNG TISSUE Niigata University BERRY, LAYLA D 1693 §102 Non-Final OA — Pending Mar 22, 2024
18613233 POWER STATION HAVING MULTIPLE CHARGING SYSTEMS Bollinger Industries, Inc. GRANT, ROBERT J 2859 §102§103 Non-Final OA — Pending Mar 22, 2024
18604709 TRANSGLUTAMINASE CONJUGATION METHOD AND LINKER Paul Scherrer Institut XIAO, YAN 1642 §102§112Other Non-Final OA — Pending Mar 14, 2024
18598279 ANTI-PINCH FOLDABLE TROLLEY Zhejiang Beihuan Outdoor Products Co., Ltd. OLSZEWSKI, JOHN 3617 §103 Final Rejection 17d overdue Pending Mar 07, 2024
18688450 AUTOMATIC DATA PROCESSING FOR MASS SPECTROMETRY DH TECHNOLOGIES DEVELOPMENT PTE. LTD. MARINI, MATTHEW G 2853 §102§103 Final Rejection — Pending Mar 01, 2024
18684682 COMPOSITION COMPRISING PASTEURIZED AKKERMANSIA FOR THE TREATMENT OR PREVENTION OF IBS-RELATED ANXIETY The Akkermansia Company MOREAU, NASHARA LOUISE 1655 §101§102§103§112 Non-Final OA 8d overdue Pending Feb 18, 2024
18684454 COMBINATION OF A NURR1 AGONIST WITH AT LEAST ONE OF AN ALDOSTERONE ANTAGONIST, AN INSULIN MODULATOR AND A SULFONYLUREA Genesis Pharma SA BEANE, RANDALL L 1654 §102§103§112 Non-Final OA — Pending Feb 16, 2024
18439838 FUNTIONALLY MODIFIED POLYPEPTIDES AND RADIOBIOSYNTHESIS Ratio Therapeutics, Inc. STEELE, AMBER D 1658 §102§103 Final Rejection 9d overdue Pending Feb 13, 2024
18439235 Biological Fluid Concentration Devices and Methods of Use Arthrex, Inc. BERA, HENA RAKESHKUMAR 1779 §103 Final Rejection — Pending Feb 12, 2024
18439034 STABILIZATION OF OLIGONUCLEOTIDE AND OLIGONUCLEOTIDE-PROTEIN COMPLEX USING ALKYLATED PHOSPHATE UNIVERSITY OF MASSACHUSETTS MCINTOSH III, TRAVISS C 1693 §102§112 Non-Final OA — Pending Feb 12, 2024
18682626 LIPIDATED POLYMYXIN ANALOGUES Auckland UniServices Limited KATAKAM, SUDHAKAR 1658 §103§112 Non-Final OA — Pending Feb 09, 2024
18294013 METHOD FOR STABLY MAINTAINING POLY(A) TAIL SK Bioscience Co., Ltd. DUFFY, PATRICIA ANN 1645 §103 Final Rejection — Pending Jan 31, 2024
18291808 LIPID NANOPARTICLE FORMULATIONS Monash University WERTZ, ASHLEE ELIZABETH 1612 §102§103§112 Non-Final OA — Pending Jan 24, 2024
18421647 MODIFIED OLIGONUCLEOTIDES TARGETING SNPs UNIVERSITY OF MASSACHUSETTS WHITEMAN, BRIAN A 1636 §102§103§112DP Non-Final OA — Pending Jan 24, 2024
18576407 THERAPEUTIC GENE SILENCING WITH CRISPR-CAS13 The Board Of Trustees Of The University Of Illinois WARD, AARON DUREL 1636 §102§103 Non-Final OA — Pending Jan 04, 2024
18396613 BRANCHED OLIGONUCLEOTIDES UNIVERSITY OF MASSACHUSETTS ZARA, JANE J 1635 §103§112DP Non-Final OA — Pending Dec 26, 2023
18571782 MULTIRESIDUAL METHOD FOR DETECTING AND/OR QUANTIFYING AMINO ACIDS, ORGANIC ACIDS AND/OR MODIFIED NUCLEOTIDES BY MEANS OF HILIC CHROMATOGRAPHIC SEPARATION AND MS/MS Crescendo Care S.r.l. MUI, CHRISTINE T 2855 §112 Non-Final OA — Pending Dec 19, 2023
18570257 COMBINATION DOSAGE REGIME OF CD137 AND PD-L1 BINDING AGENTS BIONTECH SE METCALF, MATTHEW CURRAN 1647 §103§112DP Non-Final OA — Pending Dec 14, 2023
18570201 MARKER FOR DNA DAMAGE IN PROXIMITY OF TRANSCRIBED GENOMIC LOCI AND METHODS FOR IDENTIFYING AND/OR QUANTIFYING THESE DNA DAMAGES Fondazione Istituto Italiano Di Tecnologia HANEY, AMANDA MARIE 1682 §101§112 Final Rejection — Pending Dec 14, 2023
18569859 COMPOSITION COMPRISING DRY EXTRACT OF LYOPHILISED INTESTINAL CONTENT OF ADULT CHICKEN, RELATIVE USE AS FOOD SUPPLEMENT AND USE FOR STIMULATING THE IMMUNE SYSTEM Orbiotek Sàrl TURNER, FELICIA C 1793 §103 Final Rejection — Pending Dec 13, 2023
18568418 METHOD AND APPARATUS FOR FORMING A MICROFLUIDIC GEL STRUCTURE Mimetas B.V. ALABI, OYELEYE A 1633 §103§112 Non-Final OA — Pending Dec 08, 2023
18568410 Direct Sampling from Phase-Separated Sample for Hydrophobicity Assessment DH TECHNOLOGIES DEVELOPMENT PTE. LTD. MASKELL, MICHAEL P 2881 §102§103§112 Non-Final OA — Pending Dec 08, 2023
18568398 Bioanalysis Workflow with Direct Ejection from Phase-Separated Samples DH TECHNOLOGIES DEVELOPMENT PTE. LTD. SINES, BRIAN J 1796 §103§112 Non-Final OA — Pending Dec 08, 2023
18568747 METHOD AND COMPOSITIONS FOR NEURONAL REPROGRAMMING The Governing Council of the University of Toronto BERTOGLIO, VALARIE E 1632 §102§103 Non-Final OA — Pending Dec 08, 2023
18568404 MS Calibration for OPI-MS DH TECHNOLOGIES DEVELOPMENT PTE. LTD. GASSEN, CHRISTOPHER J 2881 §103§112 Non-Final OA — Pending Dec 08, 2023
18566868 INFORMATION PROCESSING DEVICE, INFORMATION PROCESSING METHOD, AND STORAGE MEDIUM Riken LI, SUN M 3685 §101§112 Non-Final OA — Pending Dec 04, 2023
18524456 MYCOREMEDIATION OF CONTAMINANTS Mycocycle, Inc. KANE, TREVOR LOGAN 1657 §103§112 Non-Final OA — Pending Nov 30, 2023
18565575 GENE EDITING SYSTEMS COMPRISING AN RNA GUIDE TARGETING HYDROXYACID OXIDASE 1 (HAO1) AND USES THEREOF Arbor Biotechnologies, Inc. ZARA, JANE J 1637 §112 Non-Final OA — Pending Nov 30, 2023
18522928 MODULAR PORTABLE POWER SYSTEM FOR SMALL APPLIANCE APPLICATIONS Bollinger Industries, Inc. MIKELS, MATTHEW 2876 §102 Final Rejection — Pending Nov 29, 2023
18562090 ENZYME-CONJUGATED MAGNETIC BEADS SUSPENDED IN INTERNAL STANDARD BUFFER DH TECHNOLOGIES DEVELOPMENT PTE. LTD. MONTGOMERY, ANN Y 1678 §103 Non-Final OA — Pending Nov 17, 2023
18507340 NEGATIVE PRESSURE DRAINAGE SYSTEM Shenzhen Bao'An People'S Hospital YANG, CHENG FONG 3781 §102 Non-Final OA — Pending Nov 13, 2023
18506682 UNSUPERVISED OBJECT DETECTION FROM LIDAR POINT CLOUDS Waabi Innovation Inc. FEREJA, SAMUEL D 2487 §103 Final Rejection — Pending Nov 10, 2023
18503353 SYSTEM AND METHODS FOR GENOMICS-EHR INTEGRATION Leap Of Faith Technologies, Inc. PATEL, SHERYL GOPAL 3685 §103 Final Rejection — Pending Nov 07, 2023
18501729 COMBINATION THERAPY COMPRISING A MAT2A INHIBITOR AND A TYPE II PRMT INHIBITOR Ideaya Biosciences, Inc. HUTTER, GILLIAN A 1625 §103DP Non-Final OA 8d overdue Pending Nov 03, 2023
18492635 PROBABILISTIC MULTI-PARTY AUDIO TRANSLATION Mass Luminosity, Inc. MEIS, JON CHRISTOPHER 2654 §103 Non-Final OA 27d Pending Oct 23, 2023
18556582 HUMANISED ANTIBODIES LABELLED WITH RADIONUCLIDES THAT EMIT BETA-RAYS Nihon Medi-Physics Co., Ltd. PRIEST, JESSICA MARIE 1618 §103§112DP Non-Final OA — Pending Oct 20, 2023
18556577 RADIOACTIVE ANTITUMOR AGENT Nihon Medi-Physics Co., Ltd. SCHLIENTZ, LEAH H 1618 §103 Non-Final OA — Pending Oct 20, 2023
18556260 COMPOUNDS Pathios Therapeutics Limited OTTON, ALICIA L 1699 §102§112 Non-Final OA — Pending Oct 19, 2023
18489682 W/O/W MICROEMULSIONS FOR OCULAR ADMINISTRATION UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION VANHORN, ABIGAIL LOUISE 1636 §101§103§112DP Non-Final OA — Pending Oct 18, 2023
18380871 CONJUGATES OF SIRNA AND ANTISENSE OLIGONUCLEOTIDES (SIRNASO) AND METHODS OF USE IN GENE SILENCING UNIVERSITY OF MASSACHUSETTS POLIAKOVA-GEORGAN, EKATERINA 1637 §102§103§112 Non-Final OA — Pending Oct 17, 2023
18286072 NOVEL FAMILY OF DNA POLYMERASES ACCEPTING 2-AMINOADENINE AND REJECTING ADENINE IN THEIR SUBSTRATES COMMISSARIAT À L'ÉNERGIE ATOMIQUE ET AUX ÉNERGIES ALTERNATIVES REGA, KYLE THOMAS 1636 §112Other Non-Final OA — Pending Oct 06, 2023
18283367 SYSTEMS AND METHODS FOR HUMIDITY AND/OR TEMPERATURE CONTROL IN A SAMPLE ANALYSIS SYSTEM DH TECHNOLOGIES DEVELOPMENT PTE. LTD. NGUYEN, HENRY H 1758 §103 Non-Final OA — Pending Sep 21, 2023
18368488 MOTION FORECASTING FOR AUTONOMOUS SYSTEMS Waabi Innovation Inc. ANYIKIRE, CHIKAODILI E 2487 §102§103 Non-Final OA — Pending Sep 14, 2023
18463837 DE NOVO ENGINEERING OF A BACTERIAL LIFESTYLE PROGRAM The Board Of Trustees Of The University Of Illinois WARD, AARON DUREL 1636 §103 Non-Final OA — Pending Sep 08, 2023
18549132 FUNCTIONALISED HYDROGELS Commonwealth Scientific And Industrial Research Organisation IQBAL, SYED TAHA 1736 §102 Non-Final OA — Pending Sep 05, 2023
18459412 SPRING PLATE FOR ATHLETIC SHOE MIDSOLE Hettas Sport Ltd. NUNNERY, GRADY ALEXANDER 3732 §103 Final Rejection — Pending Aug 31, 2023
18453098 FCRN BINDING POLYPEPTIDES The Board Of Trustees Of The University Of Illinois GUSTILO, ESTELLA M 1646 §102§103§112 Non-Final OA — Pending Aug 21, 2023
18277211 ROBOTIC SYSTEM MODELLING United Kingdom Atomic Energy Authority HOANG, SON T 2169 §101§102§112 Non-Final OA — Pending Aug 14, 2023
18276762 BODY TEMPERATURE LOWERING AGENT, BODY TEMPERATURE ELEVATION SUPPRESSOR, FOOD COMPOSITION FOR LOWERING BODY TEMPERATURE,AND FOOD COMPOSITION FOR SUPPRESSING BODY TEMPERATURE ELEVATION UNIVERSITY OF TSUKUBA ROZOF, TIMOTHY R 1625 §102 Final Rejection 56d Pending Aug 10, 2023
18361156 MODULAR MULTI-PANEL SOLAR CELL 4D Vision Corp. CANNON, RYAN SMITH 1726 §102 Non-Final OA 114d overdue Pending Jul 28, 2023
18274605 METHOD AND MEANS FOR MODULATING B-CELL MEDIATED IMMUNE RESPONSES UNIVERSITAET ULM CHANDRA, GYAN 1674 §102§103§112 Non-Final OA — Pending Jul 27, 2023
18274624 METHOD AND MEANS FOR MODULATING B-CELL MEDIATED IMMUNE RESPONSES UNIVERSITAET ULM NICKOL, GARY B 1643 §101§102§112DP Non-Final OA — Pending Jul 27, 2023
18349606 FUSED TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS G12V MUTANTS Incyte Corporation DEKARSKE, MADELINE MCGUIRE 1622 §103Other Final Rejection 46d Pending Jul 10, 2023
18271660 MARKER FOR ASSISTING IN DIAGNOSIS OF NEPHROTIC SYNDROME AND USE THEREOF Niigata University NGUYEN, NAM P 1678 §101§103§112 Final Rejection — Pending Jul 10, 2023
18271112 MEDIUM FOR CULTURING AND EXPANDING NEPHRON PROGENITOR CELLS, METHOD FOR CULTURING AND EXPANDING NEPHRON PROGENITOR CELLS, AND METHOD FOR PRODUCING RENAL ORGANOIDS Rege Nephro Co., Ltd. O'NEILL, MARISOL ANN 1633 §102§103§112 Final Rejection 21d Pending Jul 06, 2023
18341210 BOYSENBERRY COMPOSITIONS AND METHODS OF PREPARATION AND USE THEREOF The New Zealand Institute for Plant and Food Research Limited VISONE, THOMAS J 1672 Other Non-Final OA 70d Pending Jun 26, 2023
18269668 CLINICAL LABORATORY AUTOMATION SYSTEM WITH SINGLE CALIBRATOR DH TECHNOLOGIES DEVELOPMENT PTE. LTD. MUI, CHRISTINE T 1797 §102§103 Final Rejection 53d Pending Jun 26, 2023
18213505 MODIFIED GUIDE RNAS FOR CRISPR GENOME EDITING UNIVERSITY OF MASSACHUSETTS KONOPKA, CATHERINE ANNE 1635 §103§112 Non-Final OA — Pending Jun 23, 2023
18257177 BI-FUNCTIONAL LINEAR FUSION COLLAGEN-LOCALIZED IMMUNOMODULATORY MOLECULES AND METHODS THEREOF Cullinan Amber Corp. CESARE, JOSEPH DAVID 1675 §103 Final Rejection — Pending Jun 13, 2023
18039091 NON AGGREGATING MICROFLUIDIC MIXER AND METHODS THEREFOR Global Life Sciences Solutions Canada Ulc INSLER, ELIZABETH 1774 §102§103 Non-Final OA 11d overdue Pending May 26, 2023
18038653 BIOMOLECULE STRUCTURE DETECTION PROBE, BIOMOLECULE STRUCTURE DETECTION KIT, AND METHOD FOR DETECTING BIOMOLECULE STRUCTURE Kyushu University, National University Corporation LUSI, ELLIS FOLLETT 1677 §102 Final Rejection — Pending May 24, 2023
18252896 METHOD FOR DETECTING AND/OR QUANTIFYING A METAL ELEMENT IN A BIOLOGICAL LIQUID Cardiovascular Lab S.r.l. GAMBLE JR, RANDALL LEE 1795 §103§112 Final Rejection 14d Pending May 15, 2023
18197670 USE OF LEUKEMIA-DERIVED CELLS FOR ENHANCING NATURAL KILLER (NK) CELL THERAPY Mendus B.V. LARA, CAROLINE MONSERRAT 1633 §103 Non-Final OA 92d overdue Pending May 15, 2023
18035766 COMPOSITION COMPRISING AKKERMANSIA MUCINIPHILA AND GREEN TEA EXTRACT The Akkermansia Company DEVI, SARVAMANGALA 1645 §103§112DP Final Rejection — Pending May 08, 2023
18251493 A PROCESS FOR PRODUCING EGF Chemical & Biopharmaceutical Laboratories Of Patras S.A. DABKOWSKI, ERINNE R 1654 §103§112 Non-Final OA — Pending May 02, 2023
18141166 PROTECTING OLIGONUCLEOTIDES FOR CRISPR GUIDE RNA UNIVERSITY OF MASSACHUSETTS MEYERING, SHABANA SHABBEER 1635 §103§112Other Final Rejection — Pending Apr 28, 2023
18303346 COPPER COMPLEXES FOR TREATMENT OF NEURODEGENERATIVE DISORDERS Als Therapy Development Institute SABILA, MERCY HELLEN 1654 §103§112DP Non-Final OA 60d overdue Pending Apr 19, 2023
18299344 ARTIFICIAL INTELLIGENCE HEALTH DIAGNOSTIC SYSTEM AND METHOD Evan Greebel AKOGYERAM II, NICHOLAS A 3686 §101 Final Rejection 70d Pending Apr 12, 2023
18299304 THERAPEUTIC RADIOLABELLED CONJUGATES AND THEIR USE IN THERAPY University Of Sydney CRAIG, KAILA ANGELIQUE 1618 §103DP Final Rejection 23d overdue Pending Apr 12, 2023
18027306 METHOD FOR PREPARING EFFECTOR CELLS WITH DESIRED SPECIFICITY National University Corporation Shiga University Of Medical Science ZHU, JIANJIAN 1631 §103§112DP Final Rejection 2d overdue Pending Mar 20, 2023
18120030 OLIGONUCLEOTIDES FOR APP MODULATION UNIVERSITY OF MASSACHUSETTS ALLEN, SARAH ELIZABETH 1637 §103§112 Final Rejection 2d overdue Pending Mar 10, 2023
18043075 SYSTEMS FOR CAPTURING CELLS Arthrex, Inc. TOWA, RENE T 3791 §102§103 Final Rejection — Pending Feb 27, 2023
18041918 TRANSFORMABLE PNEUMATIC SOFT STRUCTURES Massachusetts Institute Of Technology LEDERER, SARAH B 3785 §103§112 Final Rejection 30d Pending Feb 16, 2023
18107292 MULTISPECIFIC BINDING PROTEINS TARGETING CEA Dragonfly Therapeutics, Inc. HUYNH, PHUONG N 1641 §103§112 Non-Final OA — Pending Feb 08, 2023
18094695 OLIGONUCLEOTIDES FOR MECP2 MODULATION UNIVERSITY OF MASSACHUSETTS DACE DENITO, ALEXANDRA GERALDINE 1636 §103§112 Final Rejection 22d Pending Jan 09, 2023
18091651 DEVICES AND METHODS FOR SAMPLE CHARACTERIZATION Intabio, LLC CHIU, TAK LIANG 1777 §103 Non-Final OA 23d overdue Pending Dec 30, 2022
18010197 MEANS AND METHODS FOR CLASSIFYING MICROBES Université De Lausanne ELKINS, BLAKE HARRISON 1687 §101§102§103§112 Non-Final OA — Pending Dec 13, 2022
18009142 ISOTHERMAL REAL-TIME PCR METHOD FOR DETERMINING PRESENCE OF A PRE-DETERMINED NUCLEIC ACID SEQUENCE IN HUMAN SAMPLES Certus Molecular Diagnostics AG HOPPE, EMMA RUTH 1683 §102§103§112Other Final Rejection — Pending Dec 08, 2022
18008809 ISOTHERMAL REAL-TIME PCR METHOD FOR DETERMINING PRESENCE OF A PRE-DETERMINED NUCLEIC ACID SEQUENCE OF A BACTERIUM OF THE MOLLICUTES CLASS IN A SAMPLE Certus Molecular Diagnostics AG HOPPE, EMMA RUTH 1683 §103§112Other Final Rejection — Pending Dec 07, 2022
18071590 THERMODYNAMIC MEASURES ON PROTEIN-PROTEIN INTERACTION NETWORKS FOR CANCER THERAPY Csts Health Care Inc. ROSSI, VY BUI 1685 §101§103§112DP Non-Final OA — Pending Nov 29, 2022
18058059 ANTI-VIRAL DRY CLEANING PROCESS Greenearth Cleaning, LLC YOO, REGINA M 1758 §103§112 Final Rejection — Pending Nov 22, 2022
17998574 POLYNUCLEOTIDES COMPRISING AN ANTIGENIC PAYLOAD Nutcracker Therapeutics, Inc. DENT, ALANA HARRIS 1643 §102§103§112 Non-Final OA — Pending Nov 11, 2022
18049724 COMPLEXES FOR GENE DELETION AND EDITING UNIVERSITY OF MASSACHUSETTS LEONARD, ARTHUR S 1631 §103§112 Final Rejection 11d overdue Pending Oct 26, 2022
17920881 MICROFLUIDIC DEVICES WITH GAS CHANNELS FOR SAMPLE NEBULIZATION Intabio, LLC GOURLIE, LAURA ELOISE 2881 §103 Non-Final OA — Pending Oct 24, 2022
17940636 VIRAL GUIDE RNA DELIVERY BEAM THERAPEUTICS INC. DHAR, MATASHA 1632 §103 Final Rejection — Pending Sep 08, 2022
17760329 USP7 INHIBITOR FOR USE IN THE TREATMENT OF CANCER Almac Discovery Limited REILLY, SOPHIA JANE 1627 §103 Final Rejection 22d Pending Aug 08, 2022
17753034 LC Issue Diagnosis from Pressure Trace Using Machine Learning DH TECHNOLOGIES DEVELOPMENT PTE. LTD. JEONG, YOUNGSUL 1772 §103 Final Rejection — Pending Feb 16, 2022
17591681 TREATMENT OF GENETIC DISORDERS ASSOCIATED WITH DNA REPEAT INSTABILITY VICO Therapeutics B.V. ANGELL, JON E 1637 DP Non-Final OA — Pending Feb 03, 2022
17624690 COMBINATION Genesis Pharma SA D' AMBROSIO, THEA 1654 §102§112Other Non-Final OA 55d Pending Jan 04, 2022
17599282 XYLOGLUCAN-CONTAINING PRODRUGS AND METHODS OF MANUFACTURE AND USE THEREOF The Governors of the University of Alberta HIBSHMAN, SARAH GRACE 1693 §103 Non-Final OA — Pending Sep 28, 2021
17262400 METHOD FOR PRODUCING FOREIGN ANTIGEN RECEPTOR GENE-INTRODUCED CELL National University Corporation Shiga University Of Medical Science MIANO, JOSEPH PAUL 1631 §102§103§112Other Non-Final OA 87d overdue Pending Aug 27, 2021
17429754 PLASMA POLYMER NANOPARTICLES CARRYING AGENTS The Heart Research Institute Ltd. PATTERSON, SARAH COOPER 1675 DP Final Rejection — Pending Aug 10, 2021
17415842 ULTRASOUND CONTRAST AGENT AND METHODS FOR USE THEREOF GE Healthcare AS CRAIG, KAILA ANGELIQUE 1618 §103§112 Non-Final OA — Pending Jun 18, 2021
17293671 THIOAMIDE-CONTAINING COMPOSITIONS AND METHODS OF USE THEREOF Ratio Therapeutics, Inc. ELENISTE, PIERRE PAUL 1622 §103 Non-Final OA 15d Pending May 13, 2021
17235153 OLIGONUCLEOTIDES FOR MSH3 MODULATION UNIVERSITY OF MASSACHUSETTS VYAS, KEYUR ANILKUMAR 1637 §103 Non-Final OA 5d Pending Apr 20, 2021
16999759 O-METHYL RICH FULLY STABILIZED OLIGONUCLEOTIDES UNIVERSITY OF MASSACHUSETTS ARIETI, RUTH SOPHIA 1635 §103DP Non-Final OA — Pending Aug 21, 2020
16998587 TARGETED FLUORESCENT MARKERS IN COMBINATION WITH A FLEXIBLE PROBE On Target Laboratories, LLC SCHLIENTZ, LEAH H 1618 §103 Final Rejection 162d overdue Pending Aug 20, 2020
15555811 MICROPARTICLES Spheritech Ltd. LOVE, TREVOR M 1611 §102DP Final Rejection 11d overdue Pending Sep 05, 2017

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month